Breaking Barriers: Cell Therapy’s Evolution in Oncology The conclusion of 2025 American Society of Clinical Oncology (ASCO) Annual Meeting left the oncology community buzzing with excitement about groundbreaking advancements in cell therapy for refractory cancers. The conference featured 95 cell therapy-related abstracts with notable emphasis on precision medicine approaches. This represents the largest collection of cell therapy … Continue reading Cell Therapy in 2025: What ASCO’s Latest Innovations Mean for Refractory Cancers